期刊文献+

舒利迭治疗COPD患者的肺功能及凝血状态分析 被引量:3

Effect of Seretide on pulmonary function and coagulation status of patients with COPD
下载PDF
导出
摘要 目的观察舒利迭对COPD患者的肺功能及血液高凝状态的影响,并探讨其作用机制。方法 32例COPD出院患者主要采用舒利迭吸入治疗,疗程为12周。比较治疗前、后肺功能及纤维蛋白原;血小板;D-二聚体变化。结果患者治疗前后的肺功能及凝血功能有明显改善。结论舒利迭治疗COPD的临床疗效满意。能有效改善患者肺功能及凝血状态。 Objective To observe the influence of Seretide on lung function and hypercoagulability state of patients with chronic obstructive pulmonary disease (COPD). Methods 32 patients with COPD were given Seretide inhalation for 12 weeks. Lung function, fiber fibrinogen and changes of platelets and D-dimer were compared before and after the treatment. Results The improvement of lung function and blood coagulation was significant after the treatment. Conclusion Seretide has satisfactory curative effect in the treatment of COPD patients, which can effectively improve patients' lung function and coagulation status.
作者 黄纯
出处 《临床肺科杂志》 2013年第10期1823-1824,共2页 Journal of Clinical Pulmonary Medicine
关键词 舒利迭 COPD 肺功能 纤维蛋白原 血小板 D-二聚体 Seretide COPD lung function fibrinogen blood platelet D-dimer
  • 相关文献

参考文献5

二级参考文献14

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 2薛旗山,原永平,刘亚峰,赵秋红,郑力,雷芸,张平.慢性阻塞性肺疾病患者血栓前状态的研究[J].中国医药,2007,2(1):4-5. 被引量:24
  • 3李立宇,王辰,庞宝森.慢性阻塞性肺疾病与凝血-纤溶功能异常[J].国际呼吸杂志,2007,27(14):1081-1084. 被引量:40
  • 4Wouters EF, Groenewwqen KH, Dentener MA, et al. Systemic inflammation in chronic obstructive pulmonary disease : the role of exacerbations[ J]. Proc Am Thorac Soc, 2007, 4 (8) : 626 - 634.
  • 5Gan WQ, Man SF, Sent hilsevan A, et al. Association between chronic obstructive pulmonary disease and systmic inflammation:a systmic review and a meta2analysis [ J ]. Thorax , 2004, 59 ( 7 ) : 574 - 580.
  • 6Gorlacb A, Bnnello S. The cross-talk between NF-kappaB and HIF- 1 : further evidence for a significant liaison[ J]. Biochem J, 2008, 412(3) : 477 -484.
  • 7GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Revised 2011 ). www. goldeopd, com.
  • 8McCarty OJ, Mousa SA, Bray PF, et al. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood, 2000,96: 1789-1797.
  • 9Poon RT, Fan ST, Wong J. Clinical implications of circulatingangiogenesis factors in cancer patients. J Clin Oncol,2001,19:1207-1225.
  • 10吴晓莲.肺部疾病患者血浆D-二聚体水平的变化及意义[J].临床肺科杂志,2007,12(11):1168-1168. 被引量:22

共引文献761

同被引文献34

  • 1张岩.舒利迭联合沐舒坦治疗稳定期慢阻肺临床分析[J].中文科技期刊数据库(文摘版)医药卫生,2016(6):288-288. 被引量:1
  • 2慢性阻塞性肺疾病诊疗规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(1):69-76. 被引量:261
  • 3姚婉贞.慢性阻塞性肺疾病的急性加重[J].中华全科医师杂志,2004,3(4):223-224. 被引量:16
  • 4李小飞,袁玲,文志斌.炎症与血栓形成的研究进展[J].国外医学(输血及血液学分册),2005,28(5):417-420. 被引量:13
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 6MariinovKh, Petrova D, Kamenov V, et al. Anticoagulants and changes in the coagulation status of patients with chronic obstructive lung disease and various degrees of respiratory failure[J].VutrBoles, 1988,27(1):86-93.
  • 7Polo R,Malerba M,Cacciola RR,et al. Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPDpatients[J]. Intern Emerg Med, 2013,8(7) :567-574.
  • 8Alessandric C,Basili S,Violi F,et al. Hypercoagulahility state in pa- tients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group [J]. Thromb Haemost,1994,72(3) :343-346.
  • 9Dahl M,Tybjaerg-Hansen A,Vestbo J,et al. Elevated plasma fibrino- gen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001,164(6) : 1008-1011.
  • 10Barnes PJ,Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: Molecular and cellular' mechaniams[J]. Eur Respir, 2003,22 (4) :672-688.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部